|
Clinical Trials
BIO's Position Statement on Clinical Trials Registries and Dissemination of Results (June 21, 2005)
Read the statement.
BIO's Comments to FDA's Proposed Rule on Institutional Review Board (IRB) Registration Requirements (September 27, 2004)
Docket No. 2004N-0242, Federal Register: July 6, 2004 (Volume 69, Number 128, pp. 40556-40562). Read the comments. (100 KB PDF)
|
